Opioid Use in Patients With Testicular Cancer: Patterns and Risk Factors
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Testicular cancer patients receiving opioid prescriptions post-orchiectomy face higher risks of persistent opioid use. Advanced treatments like chemotherapy, but not retroperitoneal lymph node dissection alone, significantly increase this risk.
Area Of Science
- Oncology
- Urology
- Pain Management
Background
- Prescription opioid use can lead to chronic dependence, morbidity, and mortality.
- Men undergoing urologic surgery have an increased risk of persistent opioid use.
- Factors driving persistent opioid use in testicular cancer patients are not well understood.
Purpose Of The Study
- To identify factors associated with persistent opioid use after orchiectomy in testicular cancer patients.
- To investigate the impact of advanced treatments on long-term opioid requirements.
Main Methods
- Utilized the Truven Marketscan database (2009-2021) for testicular cancer patients undergoing orchiectomy.
- Excluded patients with prior opioid use or disorder, and those under 18 or lacking insurance.
- Defined opioid exposure based on prescription fills within 30 days of treatment, including pretreatment use for advanced therapy patients.
- Employed multivariable logistic regression to analyze risk factors for opioid prescriptions 31-180 days post-treatment.
Main Results
- Opioid exposure within 30 days of treatment significantly correlated with subsequent opioid prescriptions (31-90 and 91-180 days post-treatment).
- Advanced treatments, specifically chemotherapy (alone or with RPLND), were independently associated with increased opioid use 31-180 days post-treatment.
- Retroperitoneal lymph node dissection (RPLND) alone did not show a significant association with persistent opioid use.
Conclusions
- Testicular cancer patients receiving initial opioid prescriptions post-orchiectomy are at higher risk for continued use.
- Chemotherapy, with or without RPLND, is a significant risk factor for prolonged opioid dependence in this cohort.
- RPLND alone does not appear to elevate the risk of persistent opioid use after orchiectomy.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...